Target intelligence / Profile preview

B7.1 protein (CD80) (None)

Target
None
Molecular classification
Type I transmembrane glycoprotein, Immunoglobulin superfamily, Co-stimulatory molecule
01

Overview

CD80 (B7.1) is a type I transmembrane glycoprotein expressed on antigen-presenting cells (APCs) and activated T cells. It functions as a co-stimulatory molecule crucial for T-cell activation and immune regulation. CD80 interacts with CD28 to deliver a stimulatory signal and with CTLA-4 (CD152) to deliver an inhibitory signal, thereby modulating immune responses. This pathway plays a critical role in initiating primary immune responses, maintaining peripheral tolerance, and regulating autoimmunity through immune checkpoint inhibition mechanisms.

Other names
CD80Cluster of Differentiation 80B7-1
02

Mechanism of action

Modulation of T-cell activation via CD28 and CTLA-4 interaction; immune checkpoint inhibition

03

Biological functions

T-cell activationImmune regulationCo-stimulationSignal transductionMaintenance of peripheral tolerance
04

Disease associations

AutoimmunityCancerInflammation
05

Safety considerations

Potential for immune-related adverse events due to modulation of T-cell activityDisruption of immune homeostasis leading to autoimmunity or increased susceptibility to infection

Beyond the preview

Go deeper on B7.1 protein (CD80) (None).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on B7.1 protein (CD80) (None).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call